Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 28.6.2025Teva B.V. (TEV-NL-4)91376Gabapentin-Teva 300 mg (cps dur 200(2x100)x300 mg (blis.PVC/PVDC/Al))15.8.2025R
 28.6.2025Teva B.V. (TEV-NL-4)91386Gabapentin-Teva 400 mg (cps dur 200(2x100)x400 mg (blis.PVC/PVDC/Al))1.9.2025R
 28.6.2025ratiopharm GmbH (RAT)51669Perindocombi 2 mg/0,625 mg (tbl 30x2 mg/0,625 mg (blis.PA/Al/PVC/Al))10.9.2025R
 27.6.2025Roche Registration GmbH (HLR-DE)44660MIRCERA 100 mikrogramov/0,3 ml injekčný roztok v naplnenej injekčnej striekačke (sol inj 1x0,3 ml/100 µg (napl.inj.striek.skl.))1.7.2025Z
 27.6.2025Roche Registration GmbH (HLR-DE)44654MIRCERA 75 mikrogramov/0,3 ml injekčný roztok v naplnenej injekčnej striekačke (sol inj 1x0,3 ml/75 µg (napl.inj.striek.skl.))1.7.2025Z
 27.6.2025Sandoz GmbH (SAN-A)4509ETyruko 300 mg infúzny koncentrát (con inf 1x15 ml/300 mg (liek.inj.skl.))30.6.2025U
 27.6.2025STADA Arzneimittel AG (STD)4296EOroflurb pastilky s pomarančovou príchuťou (pas ord 24x8,75 mg (blis.PVC/PVDC/Al))27.6.2025U
 27.6.2025McNeil Healthcare (Ireland) Limited (MCP-3)15853LIVOSTIN 0,5 mg/ ml (int opu 1x4 ml)1.7.2025O
 27.6.2025Bayer AG (BAY)6622DXarelto 1 mg/ml granulát na perorálnu suspenziu (gru por 1x2,625 g/51,7 mg (fľ.skl.hnedá))29.6.2025R
 26.6.2025UCB Pharma S.A. (UCP)98647Neupro 2 mg/24 h transdermálna náplasť (emp tdm 7x2 mg/24 hodín (vre.pap./LDPE/Al/ET kopolymér PE/Al/ET kopolymér/pap.))26.6.2025Z
 26.6.2025Otsuka Pharmaceutical Netherlands B.V. (OTS-NL)6077EAbilify Maintena 960 mg injekčná suspenzia s predĺženým uvoľňovaním v naplnenej injekčnej striekačke (sus iph 1x960 mg (striek.inj.napl + 2 bezp.ihly))1.8.2025U
 26.6.2025Takeda Pharmaceuticals International AG Ireland Branch (TAK-IE-1)5118DTAKHZYRO 300 mg injekčný roztok v naplnenej injekčnej striekačke (sol inj 1x300 mg (striek.inj.napl.skl.))26.6.2025U
 26.6.2025MEDOCHEMIE Ltd. (MOE)3671CMEDOCLAV 400 mg/5 ml + 57 mg/5 ml prášok na perorálnu suspenziu (plu por 1x70 ml (fľ.skl.hnedá+dáv.striek.))24.6.2025R
 26.6.2025MEDOCHEMIE Ltd. (MOE)5231BAXETINE 250 mg (tbl flm 10x250 mg (blis.Al/Al))24.6.2025O
 26.6.2025MEDOCHEMIE Ltd. (MOE-1)5425DElomen (sol inf 10x100 ml (liek.inj.skl))24.6.2025R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)